The FDA said Thursday that there are still too many unknowns about the burgeoning market for CBD products to regulate them as either food or supplements.
, is a hemp-derived compound that is offered in a wide variety of products, including lotions, tinctures, drinks, and even pet supplements. Because hemp has less than .3% THC, the mind-altering substance in marijuana, the products do not cause a "high."
CBD could potentially be harmful to the liver, the male reproductive system, and pregnant women, officials said Thursday. would benefit consumers by providing safeguards and oversight to manage and minimize risks related to CBD products," FDA Deputy Commissioner Dr. Janet Woodcock said in a statement.
The CBD market was valued at $9.1 billion worldwide in 2021 and could reach $59.3 billion by 2030, according to a report last year by Market Research Future.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
FDA declines to regulate CBD; calls on Congress for fixThe Food and Drug Administration says there are too many unknowns about CBD products to regulate them as foods or supplements
ادامه مطلب »
FDA declines to regulate CBD; calls on Congress for fixThe Food and Drug Administration said Thursday there are too many unknowns about CBD products to regulate them as foods or supplements under the agency’s current structure and called on Congress to create new rules for the massive and growing market.
ادامه مطلب »
FDA declines to regulate CBD and calls on Congress for a fixThe Food and Drug Administration says there are too many unknowns about CBD products to regulate them as foods or supplements.
ادامه مطلب »
FDA declines to regulate CBD; calls on Congress for fixThe Food and Drug Administration says there are too many unknowns about CBD products to regulate them as foods or supplements
ادامه مطلب »
FDA Calls for New Powers to Regulate CBD ProductsCBD oils and other cannabis-derived products require closer regulation because of safety risks, the Food and Drug Administration said, as it seeks new powers to regulate cannabidiol products from Congress
ادامه مطلب »
FDA says new process is needed for regulating CBD products due to risksThe FDA said after 'careful review' it has determined that its current framework for evaluating food and supplements is not set up well for CBD because of safety risks.
ادامه مطلب »